Literature DB >> 16898117

Palliative radiation therapy for canine osteosarcoma.

Monique N Mayer1, Candace K Grier.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16898117      PMCID： PMC1482437     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  18 in total

1.  Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors:  M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.

Authors:  Christopher M Peters; Joseph R Ghilardi; Cathy P Keyser; Kazufumi Kubota; Theodore H Lindsay; Nancy M Luger; David B Mach; Matthew J Schwei; Molly A Sevcik; Patrick W Mantyh
Journal:  Exp Neurol       Date:  2005-05       Impact factor: 5.330

3.  Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs.

Authors:  Fabienne Mueller; Valerie Poirier; Katja Melzer; Dagmar Nitzl; Malgorzata Roos; Barbara Kaser-Hotz
Journal:  In Vivo       Date:  2005 Jul-Aug       Impact factor: 2.155

Review 4.  Advances in understanding bone cancer pain.

Authors:  M J Goblirsch; P Zwolak; D R Clohisy
Journal:  J Cell Biochem       Date:  2005-11-01       Impact factor: 4.429

5.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Authors:  William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

Review 6.  Gabapentin: pharmacology and its use in pain management.

Authors:  M A Rose; P C A Kam
Journal:  Anaesthesia       Date:  2002-05       Impact factor: 6.955

7.  Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group.

Authors:  Augusto Caraceni; Ernesto Zecca; Cesare Bonezzi; Edoardo Arcuri; Ricardo Yaya Tur; Marco Maltoni; Marco Visentin; Giovanna Gorni; Cinzia Martini; Walter Tirelli; Massimo Barbieri; Franco De Conno
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

8.  Four fraction palliative radiotherapy for osteosarcoma in 24 dogs.

Authors:  Eric M Green; William M Adams; Lisa J Forrest
Journal:  J Am Anim Hosp Assoc       Date:  2002 Sep-Oct       Impact factor: 1.023

Review 9.  Pain control by ionizing radiation of bone metastasis.

Authors:  Luc A M-L Vakaet; Tom Boterberg
Journal:  Int J Dev Biol       Date:  2004       Impact factor: 2.203

10.  Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

Authors:  Mary Ann C Sabino; Joseph R Ghilardi; Joost L M Jongen; Cathy P Keyser; Nancy M Luger; David B Mach; Christopher M Peters; Scott D Rogers; Matthew J Schwei; Carmen de Felipe; Patrick W Mantyh
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701
View more
  7 in total

Review 1.  Recent and current clinical trials in canine appendicular osteosarcoma.

Authors:  Andrew C Poon; Arata Matsuyama; Anthony J Mutsaers
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

Review 2.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 3.  Clinical trials of immunogene therapy for spontaneous tumors in companion animals.

Authors:  Gerardo Claudio Glikin; Liliana María Elena Finocchiaro
Journal:  ScientificWorldJournal       Date:  2014-11-17

4.  Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma-In Vitro Studies.

Authors:  Anna Małek; Bartłomiej Taciak; Katarzyna Sobczak; Agnieszka Grzelak; Michał Wójcik; Józef Mieczkowski; Roman Lechowski; Katarzyna A Zabielska-Koczywąs
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

5.  A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.

Authors:  Kusum Rathore; Maria Cekanova
Journal:  Drug Des Devel Ther       Date:  2015-09-25       Impact factor: 4.162

6.  Combination Therapy with Zoledronic Acid and Parathyroid Hormone Improves Bone Architecture and Strength following a Clinically-Relevant Dose of Stereotactic Radiation Therapy for the Local Treatment of Canine Osteosarcoma in Athymic Rats.

Authors:  Ryan C Curtis; James T Custis; Nicole P Ehrhart; E J Ehrhart; Keith W Condon; Sara E Gookin; Seth W Donahue
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

7.  MicroRNA-93 promotes the tumorigenesis of osteosarcoma by targeting TIMP2.

Authors:  Hua Zhang; Jidong Zhang; Fanrui Meng; Hanzhong Zhu; Hongyu Yan; Yunliang Guo; Shandi Zhang
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.840
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.